Publications:

Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects.

Cancer Research

Ishiyama, Noboru N; O'Connor, Matthew M; Salomatov, Andrei A; Romashko, Darlene D; Thakur, Shalabh S; Mentes, Ahmet A; Hopkins, Julia F JF; Frampton, Garrett M GM; Albacker, Lee A LA; Kohlmann, Anna A; Roberts, Christopher C; Buck, Elizabeth E

Publication Date: 2022-05-03

Variant appearance in text: HER2: G292C

PubMed Link: 35503682

Variant Present in the following documents:

• Main text
• 1531.pdf

View BVdb publication page

Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer.

Thoracic Cancer

Wei, Xue-Wu XW; Gao, Xin X; Zhang, Xu-Chao XC; Yang, Jin-Ji JJ; Chen, Zhi-Hong ZH; Wu, Yi-Long YL; Zhou, Qing Q

Publication Date: 2020-06

Variant appearance in text: ERBB2: G292C

PubMed Link: 32291971

Variant Present in the following documents:

• Main text
• TCA-11-1512.pdf

View BVdb publication page

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.

Cell Reports

Way, Gregory P GP; Sanchez-Vega, Francisco F; La, Konnor K; Armenia, Joshua J; Chatila, Walid K WK; Luna, Augustin A; Sander, Chris C; Cherniack, Andrew D AD; Mina, Marco M; Ciriello, Giovanni G; Schultz, Nikolaus N; , ; Sanchez, Yolanda Y; Greene, Casey S CS

Publication Date: 2018-04-03

Variant appearance in text: ERBB2: 874G>T

PubMed Link: 29617658

Variant Present in the following documents:

• NIHMS958974-supplement-6.xlsx, sheet 1
• NIHMS958974-supplement-5.xlsx, sheet 1

View BVdb publication page